Open AccessALK‑positive locally advanced lung cancer in a patient who achieved long‑term complete response with crizotinib: A case report
Author(s) -
Levent Emirzeoğlu,
Ozgur Olmez
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11587
Subject(s) - crizotinib , anaplastic lymphoma kinase , lung cancer , medicine , oncology , alk inhibitor , oncogene , adenocarcinoma , stage (stratigraphy) , molecular medicine , cancer , complete response , cancer research , cell cycle , chemotherapy , biology , paleontology , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom